Commercialized kits to assess T-cell responses against SARS-CoV-2 S peptides. A pilot study in health care workers

Mostrar otras versiones (1)

BACKGROUND: It is crucial to assess the levels of protection generated by natural infection or SARS-CoV-2 vaccines, mainly in individuals professionally exposed and in vulnerable groups. Measuring T-cell responses may complement antibody tests currently in use as correlates of protection. Our aim wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Martínez-Gallo, Mónica, Esperalba, Juliana, Pujol-Borrell, Ricardo, Sandá, Víctor, Arrese-Muñoz, Iria, Fernández-Naval, Candela, Antón, Andrés, Cardona, Victoria, Labrador-Horrillo, Moisés, Pumarola, Tomás, Hernandéz-González, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier España, S.L.U. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389861/
https://www.ncbi.nlm.nih.gov/pubmed/35999826
http://dx.doi.org/10.1016/j.medcle.2021.09.028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389861/
https://www.ncbi.nlm.nih.gov/pubmed/35999826
http://dx.doi.org/10.1016/j.medcle.2021.09.028

Ejemplares similares